Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.52 | N/A | +7.22% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.52 | N/A | +7.22% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings beat on EPS. They emphasized the importance of operational efficiency moving forward.
We are pleased with our EPS performance this quarter.
Our focus remains on maintaining operational efficiency.
The earnings report indicates that Prestige Consumer HE is performing well in terms of earnings, as evidenced by the EPS beat. The stock reacted positively, rising by 0.48%. However, the lack of revenue data and guidance leaves some uncertainty about future performance and growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMERICAN INTL GROUP
Aug 3, 2015